Literature DB >> 6694117

Diffusion of reactive metabolites out of hepatocytes: studies with bromobenzene.

T J Monks, S S Lau, J R Gillette.   

Abstract

We have developed a simple experimental technique which allows the determination of the relative rates of intracellular inactivation of chemically reactive metabolites and their diffusion out of isolated rat hepatocytes. By using bromobenzene as a model compound we have demonstrated that bromobenzene-3, 4-oxide generated within hepatocytes is sufficiently stable to leave the endoplasmic reticulum in which it is formed, traverse the cytoplasm and cross the cell membrane to the external environment. The addition of varying amounts of protein, which serves as an external sink to trap the epoxide as a covalently bound adduct, permits the calculation of the relative rates at which the epoxide is inactivated within the cells and diffuses out of the cells. As much as 35% of bromobenzene-3,4-oxide is capable of leaving hepatocytes and being trapped as a covalently bound adduct to glutathione (GSH)-transferase B. The extensive diffusion of bromobenzene-3,4-oxide may play an important role in the intercellular toxicity of this compound within the liver and perhaps may contribute to extrahepatic toxicity. The addition of GSH-transferase B to isolated hepatocyte suspensions caused a decrease in the formation of the 3,4-dihydrodiol, p-bromophenol and o- and p-bromophenol glucuronides, an increase in the formation of bromobenzene GSH conjugates, but did not affect intracellular covalent binding. Kinetic analyses of the data revealed that, in the absence of GSH-transferase B, nearly all of the bromobenzene GSH conjugates are formed within hepatocytes as the epoxide is formed, whereas rearrangement of bromobenzene-3,4-oxide to p-bromophenol and hydration to bromobenzene-3,4-dihydrodiol occurs almost exclusively outside the hepatocytes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6694117

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Site-specific arylation of rat glutathione s-transferase A1 and A2 by bromobenzene metabolites in vivo.

Authors:  Yakov M Koen; Weimin Yue; Nadezhda A Galeva; Todd D Williams; Robert P Hanzlik
Journal:  Chem Res Toxicol       Date:  2006-11       Impact factor: 3.739

2.  Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues.

Authors:  R J Riley; P Roberts; M D Coleman; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

3.  Activation and toxicity of bromobenzene in nasal tissue in mice.

Authors:  E B Brittebo; C Eriksson; I Brandt
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

4.  Formation of epoxide and quinone protein adducts in B6C3F1 mice treated with naphthalene, sulfate conjugate of 1,4-dihydroxynaphthalene and 1,4-naphthoquinone.

Authors:  L S Tsuruda; M W Lamé; A D Jones
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

5.  The fate of benzene-oxide.

Authors:  Terrence J Monks; Michael Butterworth; Serrine S Lau
Journal:  Chem Biol Interact       Date:  2009-12-29       Impact factor: 5.192

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.